PTEN and neoplasm: The percentage of PTEN labeled nuclei in tumor samples with activating EGFR or PI3K mutations was higher than in tissues with EGFR and PI3K wild type displaying 62%+31 (score 3+) vs 39%+26 (score 2+) respectively (p = 0.032).